43 , 50 In our cohort, patients receiving TKIs plus anti-PD-1 showed a numerically higher rate of HBV DNA negative conversion and greater HBsAg decline than those receiving TKIs alone, although the differences did not reach statistical significance.
← all excerpts
Esophagogastric Variceal Bleeding in Cirrhotic Patients with Hepatocellular Carcinoma Receiving Systemic Therapy: A Retrospective Cohort Study.
1
—
—